Interleukin-6 and airflow limitation in chemical warfare patients with chronic obstructive pulmonary disease.
Attaran
Davood
D
Lung Disease and Tuberculosis Research Center, Mashhad University of Medical Science, Tehran, Iran.
Lari
Shahrzad M
SM
Towhidi
Mohammad
M
Marallu
Hassan Ghobadi
HG
Ayatollahi
Hossein
H
Khajehdaluee
Mohammad
M
Ghanei
Mostafa
M
Basiri
Reza
R
D000328:Adult; D015992:Body Mass Index; D016022:Case-Control Studies; D002619:Chemical Warfare Agents / Q000506:poisoning*; D003430:Cross-Sectional Studies; D004417:Dyspnea / Q000209:etiology; D005080:Exercise Test; D017079:Exercise Tolerance; D005541:Forced Expiratory Volume; D006801:Humans; D018836:Inflammation Mediators / Q000097:blood*; D015850:Interleukin-6 / Q000097:blood*; D007492:Iran; D008168:Lung / Q000503:physiopathology*; D008297:Male; D008875:Middle Aged; D009151:Mustard Gas / Q000506:poisoning*; D029424:Pulmonary Disease, Chronic Obstructive / Q000139:chemically induced* / Q000276:immunology / Q000503:physiopathology; D011788:Quality of Life; D012720:Severity of Illness Index; D013147:Spirometry; D011795:Surveys and Questionnaires; D015854:Up-Regulation; D014728:Veterans; D014797:Vital Capacity
D002619:Chemical Warfare Agents; C508600:IL6 protein, human; D018836:Inflammation Mediators; D015850:Interleukin-6; D009151:Mustard Gas
chemical warfare; chronic obstructive pulmonary disease; inflammation; interleukin-6; sulfur mustard